|
high-discriminatively polypyrrole receptor for enhanced specificity in creatinine detection for early-stage chronic kidney disease
|
01-10-202330-09-2025
|
Penyelidik Bersama
|
|
ikaros protein and its relationship with lupus nephritis : a pilot case-control study
|
21-09-202320-09-2025
|
Ketua Projek
|
|
seroprevalence of strongyloides stercoralis among advanced chronic kidney disease patients
|
22-06-202321-06-2025
|
Penyelidik Bersama
|
|
discover careme global registry: real world data on patient management and quality of care
|
20-05-202119-05-2025
|
Penyelidik Bersama
|
|
predictors of early remission and organ damage among systemic lupus erythematosus (sle) patients in malaysia: a multi-centre study
|
24-08-202323-02-2025
|
Penyelidik Bersama
|
|
a multicentre international randomized parallel group double-blind placebo-controlled clinical trial of empagliflozin once daily to assess cardio-renal outcomes in patients with chronic kidney disease
|
13-09-201812-09-2024
|
Penyelidik Bersama
|
|
the effects of weekly glucagon-like peptide-1 receptor agonist (glp-1 ra) semaglutide on glycaemic variability in subjects with type 2 diabetes mellitus and end stage renal disease
|
09-12-202108-09-2024
|
Penyelidik Bersama
|
|
randomised, double-blind (within dose groups), placebo-controlled and parallel group trial to investigate the effects of different doses of oral bi 685509 given over 20 weeks on uacr reduction in patients with non-diabetic kidney disease.
|
04-05-202130-06-2024
|
Penyelidik Bersama
|
|
a phase 2b randomised, double-blind, placebo-controlled, multi-centre, dose-ranging study of azd5718 in participants with proteinuric chronic kidney disease
|
24-01-202123-01-2024
|
Penyelidik Bersama
|
|
elucidating the dysbiosis of firmicutes/bacteroidetes in the gut in signaling the activation of t regulatory cells, interferon alfa (ifn-Ī±), and interleukin 6(il-6) pathway in patients with systemic lupus erythemathosus (sle).
|
01-11-202031-10-2023
|
Penyelidik Bersama
|
|
randomised, double-blind, placebo-controlled and parallel dose group trial to investigate efficacy and safety of multiple doses of oral bi 690517 over 14 weeks, alone and in combination with empagliflozin, in patients with diabetic and non-diabetic chroni
|
28-02-202227-10-2023
|
Penyelidik Bersama
|
|
a multicenter, randomized, double-blind, placebo controlled, multiple dose study to evaluate the efficacy and safety of vis649 in participants with immunoglobulin a (iga) nephropathy
|
01-06-202030-09-2023
|
Penyelidik Bersama
|
|
work disability and employment status among advanced chronic kidney disease patients
|
09-09-202108-09-2023
|
Ketua Projek
|
|
randomised, double-blind (within dose groups), placebo-controlled and parallel group trial to investigate the effects of different doses of oral bi 685509 given over 20 weeks on uacr reduction in patients with diabetic kidney disease
|
04-05-202131-08-2023
|
Penyelidik Bersama
|
|
utility of intradialytic blood culture in diagnosing catheter related bloodstream infection (crbsi)
|
01-08-202031-07-2023
|
Ketua Projek
|
|
prevalence of tuberculosis among patients with connective tissue diseases in ukmmc and their associated factors
|
27-01-202226-07-2023
|
Penyelidik Bersama
|
|
ikaros protein in systemic lupus erythematosus and its relationship with disease activity
|
28-04-202227-04-2023
|
Penyelidik Bersama
|
|
comparison of optical coherence tomography angiography parameters between diabetic chronic kidney disease and non-diabetic chronic kidney disease
|
16-01-202015-11-2022
|
Penyelidik Bersama
|
|
adverse effects after covid-19 vaccination in patients with autoimmune disease
|
25-10-202124-10-2022
|
Penyelidik Bersama
|
|
the prevalence of chronic kidney disease (ckd) and its associated risk factors in people living with human immunodeficiency virus (plhiv) in ukmmc
|
15-07-202114-07-2022
|
Ketua Projek
|
|
study prevalence of infection related hospital admission among systemic lupus erythematosus patients and its associated factors
|
26-08-202125-06-2022
|
Penyelidik Bersama
|
|
a pilot study assessing angiotensināconverting enzyme ii (ace2) expression in the in fectivity and severity of covid-19
|
15-05-202014-05-2022
|
Penyelidik Bersama
|
|
the assessment of attitude of healthcare workers towards organ donation
|
24-06-202123-12-2021
|
Ketua Projek
|
|
prevalence of platelet dysfunction and its association with urea level in chronic kidney disease
|
11-06-202010-11-2021
|
Penyelidik Bersama
|
|
work disability and employment status among end stage renal disease patients starting on dialysis
|
10-09-202009-09-2021
|
Ketua Projek
|
|
epidemiology and long-term outcome of critically ill patients requiring renal replacement therapy in southeast asia and india (insea-rrt registry)
|
21-08-201920-08-2021
|
Penyelidik Bersama
|
|
caregivers burdens among patients on chronic dialysis in malaysia-a single centre study
|
23-07-202022-07-2021
|
Ketua Projek
|
|
the association of retinal vessel caliber, tortuosity and macula volume changes with ckd progression in diabetics vs non-diabetics over a one year period
|
12-09-201911-03-2021
|
Penyelidik Bersama
|
|
the use of intravenous pamidronate in dialysis patients undergoing parathyroidectomy
|
09-02-201808-02-2021
|
Ketua Projek
|
|
aetiological spectrum of chronic kidney disease in ukm medical centre
|
24-01-201923-01-2021
|
Ketua Projek
|
|
maternal and foetal outcomes in pregnant women with underlying ckd in ukmmc
|
25-07-201924-07-2020
|
Penyelidik Bersama
|
|
catheter related blood stream infections and catheter colonisers among dialysis patients in universiti kebangsaan malaysia medical centre (ukmmc): prevalence, risk factors and outcomes
|
26-09-201925-06-2020
|
Penyelidik Bersama
|
|
effects of oral calcitriol in the treatment of biopsy proven immunoglobulin a nephropathy: randomised control clinical study
|
25-09-201824-03-2020
|
Penyelidik Bersama
|
|
access to renal transplantation and post-transplantation prognosis (retrapp) study of adults in malaysia
|
24-12-201723-06-2019
|
Penyelidik Bersama
|
|
a randomised, open-label, parallel group, multi-centre controlled study to evaluate the clinical performance and safety of stay safe linkr compared with stay safer in patients with end-stage kidney disease on continuous ambulatory peritoneal dialysis (cap
|
26-10-201725-03-2019
|
Penyelidik Bersama
|
|
the efficacy of combination treatment of haemoperfusion and haemodialysis versus haemodiafiltration in removing middle molecule uraemic toxins in end stage renal disease patients
|
12-10-201711-12-2018
|
Penyelidik Bersama
|